STRONGBRIDGE BIOPHARMA plc Deferred Tax Assets, Net of Valuation Allowance
STRONGBRIDGE BIOPHARMA plc had Deferred Tax Assets, Net of Valuation Allowance of $577.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-03.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2021-03-03
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $577.00K.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $219.00K.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.96M.
- 2015-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.19M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2020-12-31 | $577.00K 10-K · filed 2021-03-03 |
| 2019-12-31 | $219.00K 10-K · filed 2021-03-03 |
| 2016-12-31 | $1.96M 10-K · filed 2018-03-12 |
| 2015-12-31 | $1.19M 20-F · filed 2017-04-04 |
| 2014-12-31 | $735.00K 20-F · filed 2016-03-24 |